62
Research Trials
22
Peer-reviewed publications
17
Clinical Conditions

Updated interim data from 54 COPD patients and 135,000 monitored hours, showing cough rates rise in the days before exacerbations and correlate only weakly with CAT scores.

A month of continuous monitoring in stable chronic cough shows that multi-day averaging makes cough frequency a more reliable trial endpoint, allowing smaller studies, and reveals a short-lived Hawthorne effect.

Mixed-methods study in Kampala assessing 48-hour cough frequency monitoring with the Hyfe Research app for TB screening and triage, alongside staff-reported implementation barriers.
18 June 2026

COPD exacerbations are still detected largely through patient-reported symptoms. This prospective, multi-center study in Navarra, Spain (NCT07212439) is evaluating whether continuous passive cough monitoring with the Hyfe CoughMonitor can characterize cough in COPD and detect exacerbations earlier. Treating clinicians are blinded to cough data, and exacerbations are diagnosed per GOLD 2025 criteria.
In this first interim analysis, 11 participants contributed over 16,000 hours of monitoring with 98.5% adherence. Cough rates varied little across GOLD stages but more across BODE scores, suggesting cough burden reflects disease dimensions beyond airflow limitation. Marked day-to-day variability was seen within individuals, and early findings point to detectable changes in cough patterns before exacerbations.